cytokines

Make a delay and accumulation of outstanding tasks Full stop
Biotech

Ascendis axes IL-2 program in retreat from oncology expansion

Ascendis ended development of its IL-2 candidate, pivoting away from oncology and calling time on an asset it once tipped for accelerated approval.
Nick Paul Taylor May 7, 2026 10:10am
pipeline pipes RD research

Zymeworks drops clinical-stage TCE over benefit-risk profile

Sep 2, 2025 8:10am
paint mural street artist spray paint woman painting

Mural's IL-2 flop triggers 90% staff reduction

Apr 15, 2025 9:33am
Upside-down hourglass

RANKL cytokine makes the thymus more youthful in mice

Dec 5, 2024 11:45am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Ipsen taps Biomunex's MAITs to treat solid tumors in $610M bet

Dec 3, 2024 6:00am
Graphic image of puzzle pieces missing from a persons brain a symbol of degeneration andor the improvement of it

Coya shares data on IL-2 prospect in small Alzheimer's study

Oct 29, 2024 7:55am